Citius Oncology Ownership | Who Owns Citius Oncology?


OverviewChart

Citius Oncology Ownership Summary


Citius Oncology is owned by 14.24% institutional investors, 79.64% insiders, and 6.12% retail investors.

CTOR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCitius Oncology14.24%79.64%6.12%
SectorHealthcare Stocks 35.49%11.75%52.76%
IndustryDrug Manufacturers - General Stocks45.52%6.03%48.45%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202613-23.53%14,247,638107.66%1423.15%9-10.00%1-75.00%
Dec 31, 2025176.25%6,861,177-17.90%76.03%10-23.08%4100.00%
Sep 30, 202516128.57%8,357,1593573.61%1111285.28%13160.00%2100.00%
Jun 30, 20257-227,49294.43%-1189.17%566.67%1-
Mar 31, 20257-36.36%117,007-41.75%-207.44%3-57.14%1-

Insider Transactions Trends


DateBuySell
2024 Q3--

CTOR Ownership FAQ


Who Owns Citius Oncology?

Citius Oncology shareholders are primarily institutional investors at 14.24%, followed by 79.64% insiders and 6.12% retail investors. The average institutional ownership in Citius Oncology's industry, Drug Manufacturers - General Stocks, is 45.52%, which Citius Oncology falls below.

Does Blackrock own Citius Oncology?

BlackRock is not among the top 10 institutional shareholders of Citius Oncology.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools